Authors:
Hainsworth, JD
Burris, HA
Calvert, SW
Willcutt, NT
Scullin, DC
Bramham, J
Greco, FA
Citation: Jd. Hainsworth et al., Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network, CANCER INV, 19(4), 2001, pp. 335-339
Authors:
Hainsworth, JD
Burris, HA
Yardley, DA
Bradof, JE
Grimaldi, M
Kalman, LA
Sullivan, T
Baker, M
Erland, JB
Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel in the treatment of elderly patients with advanced breastcancer: A Minnie Pearl Cancer Research Network phase II trial, J CL ONCOL, 19(15), 2001, pp. 3500-3505
Authors:
Meluch, AA
Greco, FA
Burris, HA
O'Rourke, T
Ortega, G
Steis, RG
Morrissey, LH
Johnson, V
Hainsworth, JD
Citation: Aa. Meluch et al., Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: A phase II trial of the Minnie Pearl CancerResearch Network, J CL ONCOL, 19(12), 2001, pp. 3018-3024
Citation: Jd. Hainsworth et al., Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small cell lung cancer, SEMIN ONCOL, 28(3), 2001, pp. 21-25
Citation: Jd. Hainsworth et al., Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: A review of the Sarah Cannon Cancer Center Experience, SEMIN ONCOL, 28(2), 2001, pp. 43-47
Authors:
Hainsworth, JD
Burris, HA
Billings, FT
Bradof, JE
Baker, M
Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma - Phase II trials of the Minnie Pearl Cancer Research Network, CANCER, 92(9), 2001, pp. 2391-2398
Authors:
Greco, FA
Burris, HA
Gray, JR
Raefsky, EL
Dobbs, C
Smith, S
Rinaldi, D
Morrissey, LH
Erland, JB
Litchy, S
Hainsworth, JD
Citation: Fa. Greco et al., Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy forresected nonsmall cell lung carcinoma - A feasibility study of the Minnie Pearl Cancer Research Network, CANCER, 92(8), 2001, pp. 2142-2147
Authors:
Hainsworth, JD
Burris, HA
Meluch, AA
Baker, MN
Morrissey, LH
Greco, FA
Citation: Jd. Hainsworth et al., Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas - Results of a phase II trial, CANCER, 92(3), 2001, pp. 642-649
Authors:
Thirion, P
Piedbois, P
Buyse, M
O'Dwyer, PJ
Cunningham, D
Man, A
Greco, FA
Colucci, G
Kohne, CH
Di Costanzo, F
Piga, A
Palmeri, S
Dufour, P
Cassano, A
Pajkos, G
Pensel, R
Aykan, NF
Marsh, J
Seymour, T
Citation: P. Thirion et al., Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer, BR J CANC, 84(5), 2001, pp. 611-618
Authors:
Hainsworth, JD
Burris, HA
Morrissey, LH
Thomas, M
Erland, JB
Butts, JA
Joseph, G
Kalman, L
Greco, FA
Citation: Jd. Hainsworth et al., Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network, CANCER J, 6(3), 2000, pp. 151-156
Authors:
Meluch, AA
Burris, HS
Greco, FA
Hainsworth, JD
Citation: Aa. Meluch et al., Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium, EUR J CANC, 36, 2000, pp. S30-S33
Authors:
Greco, FA
Erland, JB
Morrissey, LH
Burris III, HA
Hermann, RC
Steis, R
Thompson, D
Gray, J
Hainsworth, JD
Citation: Fa. Greco et al., Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin, ANN ONCOL, 11(2), 2000, pp. 211-215
Citation: Jd. Hainsworth et al., Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site, J CL ONCOL, 18(3), 2000, pp. 632-635
Authors:
Burris, HA
Hainsworth, JD
Erland, JB
Morrissey, LH
Kalman, LA
Hon, JK
Scullin, DC
Smith, SW
Greco, FA
Citation: Ha. Burris et al., Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer, SEMIN ONCOL, 27(1), 2000, pp. 9-13
Authors:
Hainsworth, JD
Burris, HA
Litchy, S
Morrissey, LH
Barton, JH
Bradof, JE
Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma - A Minnie Pearl Cancer Research Network Phase II trial, CANCER, 89(2), 2000, pp. 328-333
Authors:
Greco, FA
Burris, HA
Erland, JB
Gray, JR
Kalman, LA
Schreeder, MT
Hainsworth, JD
Citation: Fa. Greco et al., Carcinoma of unknown primary site - Long term follow-up after treatment with paclitaxel, carboplatin, and etoposide, CANCER, 89(12), 2000, pp. 2655-2660
Authors:
Hainsworth, JD
Burris, HA
Litchy, S
Erland, JB
Hon, JK
Brierre, JE
Greco, FA
Citation: Jd. Hainsworth et al., Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients - A minnie pearl cancer research network Phase II trial, CANCER, 88(6), 2000, pp. 1353-1358
Authors:
Hainsworth, JD
Burris, HA
Morrissey, LH
Litchy, S
Scullin, DC
Bearden, JD
Richards, P
Greco, FA
Citation: Jd. Hainsworth et al., Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma, BLOOD, 95(10), 2000, pp. 3052-3056